BMRN Financial Facts
Interest expense: -1.73MCollaborative agreement revenues: 135K
See Full Income Statement
Other long-term liabilities: 29.54M
Short-term investments: 247.5M
See Full Balance Sheet
Earnings History for BioMarin Pharmaceutical Inc. (BMRN)
|
Expand Research on BMRN
| Next EPS Date | 7/31/13 *Est. | EPS Growth Rate | -47.6% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -3.7% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +2.8% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
2/21/13  |
 |
Q412 | -$0.43 | -$0.27 | -$0.16 | $130.96M | $129.7M | N/A / N/A | = | +20.2% | Details |
| 2/16/12 |
|
Q411 | -$0.23 | -$0.11 | -$0.12 | $107.9M | $115.3M | N/A / N/A | = | +69.3% | Details |
| 4/26/12 |
|
Q112 | -$0.21 | -$0.14 | -$0.07 | $116.6M | $119.24M | N/A / N/A | = | +81.3% | Details |
| 8/1/12 |
|
Q212 | -$0.27 | -$0.21 | -$0.06 | $124M | $121.54M | $-0.08 / $122.42M | = | +68.4% | Details |
| 4/25/13 |
|
Q113 | -$0.31 | -$0.29 | -$0.02 | N/A | $131.44M | N/A / N/A | = | +2% | Details |
| 7/28/11 |
|
Q211 | -$0.05 | -$0.11 | +$0.06 | $110.63M | $105.9M | N/A / N/A |  |
+118.5% | Details |
| 4/28/11 |
|
Q111 | -$0.04 | -$0.10 | +$0.06 | $109.46M | $103.8M | N/A / N/A | |
+141.9% | Details |
| 10/28/10 |
|
Q310 | $0.06 | -$0.01 | +$0.07 | N/A | N/A | N/A / N/A | N/A | +160% | Details |
